![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Galnt16 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Galnt16 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of GALNT16 mRNA | CTD | PMID:22206623 | Galnt16 | Rat | 17beta-estradiol | increases expression | ISO | Galnt16 (Mus musculus) | 6480464 | Estradiol results in increased expression of GALNT16 mRNA | CTD | PMID:19484750 | Galnt16 | Rat | 17beta-estradiol | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of GALNT16 mRNA | CTD | PMID:30165855 | Galnt16 | Rat | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:36804509 | Galnt16 | Rat | 2,4-D | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:37567420 | Galnt16 | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Galnt16 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GALNT16 mRNA | CTD | PMID:20188158 | Galnt16 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GALNT16 mRNA | CTD | PMID:28628672 | Galnt16 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GALNT16 mRNA | CTD | PMID:36041667 | Galnt16 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Galnt16 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of GALNT16 mRNA | CTD | PMID:28973697 | Galnt16 | Rat | acrylamide | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of GALNT16 mRNA | CTD | PMID:32763439 | Galnt16 | Rat | adefovir pivoxil | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | adefovir dipivoxil results in decreased expression of GALNT16 mRNA | CTD | PMID:25596134 | Galnt16 | Rat | aflatoxin B1 | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of GALNT16 mRNA | CTD | PMID:21641981 and PMID:32234424 | Galnt16 | Rat | aflatoxin B1 | decreases methylation | ISO | GALNT16 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of GALNT16 gene | CTD | PMID:27153756 | Galnt16 | Rat | aldehydo-D-glucose | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:37567420 | Galnt16 | Rat | antirheumatic drug | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of GALNT16 mRNA | CTD | PMID:24449571 | Galnt16 | Rat | arsane | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALNT16 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALNT16 mRNA | CTD | PMID:39836092 | Galnt16 | Rat | arsenic atom | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALNT16 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALNT16 mRNA | CTD | PMID:39836092 | Galnt16 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of GALNT16 gene | CTD | PMID:35440735 | Galnt16 | Rat | Azoxymethane | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT16 mRNA | CTD | PMID:29950665 | Galnt16 | Rat | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of GALNT16 mRNA | CTD | PMID:21839799 | Galnt16 | Rat | benzo[a]pyrene | increases methylation | ISO | Galnt16 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of GALNT16 exon and Benzo(a)pyrene results in increased methylation of GALNT16 intron | CTD | PMID:27901495 | Galnt16 | Rat | benzo[a]pyrene | increases methylation | ISO | GALNT16 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of GALNT16 promoter | CTD | PMID:27901495 | Galnt16 | Rat | benzo[a]pyrene | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of GALNT16 mRNA | CTD | PMID:26238291 and PMID:32234424 | Galnt16 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of GALNT16 mRNA | CTD | PMID:31163220 | Galnt16 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GALNT16 mRNA | CTD | PMID:25181051 | Galnt16 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GALNT16 mRNA | CTD | PMID:36041667 | Galnt16 | Rat | bisphenol A | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of GALNT16 mRNA | CTD | PMID:27685785 | Galnt16 | Rat | bisphenol F | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GALNT16 mRNA | CTD | PMID:28628672 | Galnt16 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of GALNT16 mRNA | CTD | PMID:36041667 | Galnt16 | Rat | butanal | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of GALNT16 mRNA | CTD | PMID:26079696 | Galnt16 | Rat | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of GALNT16 mRNA | CTD | PMID:19167457 | Galnt16 | Rat | carbon nanotube | increases expression | ISO | Galnt16 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Galnt16 | Rat | CGP 52608 | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to GALNT16 gene] | CTD | PMID:28238834 | Galnt16 | Rat | chloroacetaldehyde | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | chloroacetaldehyde results in decreased expression of GALNT16 mRNA | CTD | PMID:25596134 | Galnt16 | Rat | cisplatin | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of GALNT16 mRNA | CTD | PMID:25596134 | Galnt16 | Rat | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of GALNT16 mRNA | CTD | PMID:20187946 | Galnt16 | Rat | cyclosporin A | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GALNT16 mRNA | CTD | PMID:25596134 | Galnt16 | Rat | D-glucose | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:37567420 | Galnt16 | Rat | dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of GALNT16 mRNA] | CTD | PMID:20032058 | Galnt16 | Rat | dexamethasone | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GALNT16 mRNA | CTD | PMID:28628672 | Galnt16 | Rat | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of GALNT16 mRNA | CTD | PMID:20032058 | Galnt16 | Rat | dextran sulfate | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT16 mRNA | CTD | PMID:29950665 | Galnt16 | Rat | dioxygen | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of GALNT16 mRNA | CTD | PMID:25596134 | Galnt16 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of GALNT16 mRNA | CTD | PMID:25152437 | Galnt16 | Rat | dorsomorphin | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Galnt16 | Rat | doxorubicin | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of GALNT16 mRNA | CTD | PMID:29803840 | Galnt16 | Rat | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of GALNT16 mRNA | CTD | PMID:30307764 | Galnt16 | Rat | fructose | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:37567420 | Galnt16 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of GALNT16 mRNA | CTD | PMID:27387713 | Galnt16 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of GALNT16 mRNA | CTD | PMID:33387578 | Galnt16 | Rat | glucose | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:37567420 | Galnt16 | Rat | hydroxyurea | increases mutagenesis | ISO | Galnt16 (Mus musculus) | 6480464 | Hydroxyurea results in increased mutagenesis of GALNT16 gene | CTD | PMID:16868089 | Galnt16 | Rat | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of GALNT16 mRNA | CTD | PMID:21396975 | Galnt16 | Rat | indometacin | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of GALNT16 mRNA | CTD | PMID:28628672 | Galnt16 | Rat | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of GALNT16 mRNA | CTD | PMID:20080153 | Galnt16 | Rat | lipopolysaccharide | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | Galnt16 | Rat | malathion | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Malathion results in increased expression of GALNT16 mRNA | CTD | PMID:37047231 | Galnt16 | Rat | manganese atom | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALNT16 mRNA | CTD | PMID:39836092 | Galnt16 | Rat | manganese(0) | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALNT16 mRNA | CTD | PMID:39836092 | Galnt16 | Rat | manganese(II) chloride | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALNT16 mRNA | CTD | PMID:39836092 | Galnt16 | Rat | methylmercury chloride | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of GALNT16 mRNA | CTD | PMID:23179753 | Galnt16 | Rat | Muraglitazar | decreases expression | EXP | | 6480464 | muraglitazar results in decreased expression of GALNT16 mRNA | CTD | PMID:21515302 | Galnt16 | Rat | N-methyl-N-nitrosourea | increases mutagenesis | ISO | Galnt16 (Mus musculus) | 6480464 | Methylnitrosourea results in increased mutagenesis of GALNT16 gene | CTD | PMID:16868089 | Galnt16 | Rat | nickel atom | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Nickel results in decreased expression of GALNT16 mRNA | CTD | PMID:24768652 | Galnt16 | Rat | O-methyleugenol | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of GALNT16 mRNA | CTD | PMID:32234424 | Galnt16 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GALNT16 mRNA | CTD | PMID:33387578 | Galnt16 | Rat | pentanal | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | pentanal results in increased expression of GALNT16 mRNA | CTD | PMID:26079696 | Galnt16 | Rat | permethrin | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Permethrin results in increased expression of GALNT16 mRNA | CTD | PMID:37047231 | Galnt16 | Rat | phenylmercury acetate | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of GALNT16 mRNA | CTD | PMID:26272509 | Galnt16 | Rat | phenylmercury acetate | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT16 mRNA | CTD | PMID:27188386 | Galnt16 | Rat | pioglitazone | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of GALNT16 mRNA | CTD | PMID:27935865 | Galnt16 | Rat | propanal | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of GALNT16 mRNA | CTD | PMID:26079696 | Galnt16 | Rat | resveratrol | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of GALNT16 mRNA | CTD | PMID:23557933 | Galnt16 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | Galnt16 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of GALNT16 mRNA | CTD | PMID:35811015 | Galnt16 | Rat | SB 431542 | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Galnt16 | Rat | sodium arsenite | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GALNT16 mRNA | CTD | PMID:29301061 | Galnt16 | Rat | sodium arsenite | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of GALNT16 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of GALNT16 mRNA | CTD | PMID:39836092 | Galnt16 | Rat | sunitinib | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of GALNT16 mRNA | CTD | PMID:31533062 | Galnt16 | Rat | temozolomide | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of GALNT16 mRNA | CTD | PMID:31758290 | Galnt16 | Rat | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of GALNT16 mRNA | CTD | PMID:21515302 | Galnt16 | Rat | testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of GALNT16 mRNA] | CTD | PMID:20032058 | Galnt16 | Rat | testosterone | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Testosterone results in increased expression of GALNT16 mRNA | CTD | PMID:33359661 | Galnt16 | Rat | titanium dioxide | affects expression | ISO | Galnt16 (Mus musculus) | 6480464 | titanium dioxide affects the expression of GALNT16 mRNA | CTD | PMID:23557971 | Galnt16 | Rat | titanium dioxide | increases methylation | ISO | Galnt16 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of GALNT16 gene and titanium dioxide results in increased methylation of GALNT16 promoter | CTD | PMID:35295148 | Galnt16 | Rat | titanium dioxide | multiple interactions | ISO | Galnt16 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT16 mRNA | CTD | PMID:29950665 | Galnt16 | Rat | trichostatin A | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of GALNT16 mRNA | CTD | PMID:24935251 and PMID:26272509 | Galnt16 | Rat | trichostatin A | multiple interactions | ISO | GALNT16 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GALNT16 mRNA | CTD | PMID:27188386 | Galnt16 | Rat | triptonide | increases expression | ISO | Galnt16 (Mus musculus) | 6480464 | triptonide results in increased expression of GALNT16 mRNA | CTD | PMID:33045310 | Galnt16 | Rat | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of GALNT16 mRNA | CTD | PMID:21515302 | Galnt16 | Rat | valproic acid | increases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GALNT16 mRNA | CTD | PMID:19101580 more ... | Galnt16 | Rat | valproic acid | affects expression | ISO | GALNT16 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of GALNT16 mRNA | CTD | PMID:25979313 | Galnt16 | Rat | valproic acid | increases methylation | ISO | GALNT16 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of GALNT16 gene | CTD | PMID:29154799 | Galnt16 | Rat | zoledronic acid | decreases expression | ISO | GALNT16 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of GALNT16 mRNA | CTD | PMID:24714768 and PMID:25596134 | |